You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

MOEXIPRIL HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Moexipril Hydrochloride patents expire, and what generic alternatives are available?

Moexipril Hydrochloride is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, Glenmark Pharms, and Heritage. and is included in eight NDAs.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MOEXIPRIL HYDROCHLORIDE?
  • What are the global sales for MOEXIPRIL HYDROCHLORIDE?
  • What is Average Wholesale Price for MOEXIPRIL HYDROCHLORIDE?
Drug patent expirations by year for MOEXIPRIL HYDROCHLORIDE
Recent Clinical Trials for MOEXIPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of NebraskaPhase 4
Teva Pharmaceuticals USAPhase 1
UCB PharmaPhase 2

See all MOEXIPRIL HYDROCHLORIDE clinical trials

Pharmacology for MOEXIPRIL HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MOEXIPRIL HYDROCHLORIDE

US Patents and Regulatory Information for MOEXIPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454-001 Jun 2, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; moexipril hydrochloride TABLET;ORAL 076980-001 Mar 7, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 076204-001 May 8, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-002 Nov 30, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.